Scimago Lab
powered by Scopus
eISSN: 1941-5923
call: +1.631.629.4328
Mon-Fri 10 am - 2 pm EST


American Journal of Case Reports is ranked the World leading among journals dedicated to publishing clinical case reports. AJCR is indexed in Web of Science, PubMed/ PMC, Scopus

(1) CiteScore (Impact Factor - like by Scopus, Elsevier) is the number of citations received by a journal in one year to documents published in the three previous years, divided by the number of documents indexed in Scopus published in those same three years.

(2) SNIP (Source Normalized Impact per Paper) measures a source’s contextual citation impact by weighting citations based on the total number of citations in a subject field. It helps you make a direct comparison of sources in different subject fields. SNIP takes into account the characteristics of the source's subject field, which is the set of documents citing that source.

(3) SJR is weighted by the prestige of a journal. Subject field, quality, and reputation of the journal have a direct effect on the value of a citation. SJR assigns relative scores to all of the sources in a citation network. Its methodology is inspired by the Google PageRank algorithm, in that not all citations are equal. A source transfers its own 'prestige', or status, to another source through the act of citing it. A citation from a source with a relatively high SJR is worth more than a citation from a source with a lower SJR. 

Clinical case reports are an invaluable first-hand source of evidence in medicine and a tool most often used in practice to exchange information and generate a more expanded search for evidence. In addition to the “evidence of what happened”, single or multiple cases are an important basis for further and more advanced research on diagnosis, treatment effectiveness, causes and outcomes of disease. However limited their conclusions may be, case reports remain a fundamental component of medicine, contributing greatly to the advancement of health care. In today's ever-expanding Evidence-Based Medicine, case reporting require a well-defined focus, content, and structure.

Presently, only a fraction of case reports is useful for clinical decision-making and bedside-decision oriented research. Therefore, the aim of the Journal is to gather case reports across medical disciplines, thereby integrating interdisciplinary, international medical knowledge.

Published: 2019-01-21

Treatment of Hypertensive Cardiogenic Edema with Intravenous High-Dose Nitroglycerin in a Patient Presenting with Signs of Respiratory Failure: A Case Report and Review of the Literature

Fermín López-Rivera, Hector R. Cintrón Martínez, Christian Castillo LaTorre, Alexis Rivera González, Jose Gabriel Rodríguez Vélez, Vanessa Fonseca Ferrer, Omar F. Méndez Meléndez, Edgar J. Vázquez Vargas, Hernán A. González Monroig

(Department of Internal Medicine, San Juan City Hospital, San Juan, Puerto Rico)

Am J Case Rep 2019; 20:83-90

DOI: 10.12659/AJCR.913250

BACKGROUND: Pulmonary edema is the accumulation of fluid in the lung secondary to increased hydrostatic pressure. Hypertensive cardiogenic pulmonary edema presents with a sudden onset of severe dyspnea, tachycardia, and tachypnea, and can occur when the systolic blood pressure exceeds 160 mmHg in association with acute decompensated congestive cardiac failure (CCF). A case is presented of hypertensive cardiogenic pulmonary edema treated with high-dose nitroglycerin and includes a review of the literature.
CASE REPORT: A 63-year-old Hispanic male with a medical history of hypertension, coronary artery disease, heart failure with a reduced ejection fraction of 35%, chronic kidney disease (CKD) and diabetes mellitus, presented as an emergency with acute, severe dyspnea. The patient was initially managed with 100% oxygen supplementation and intravenous (IV) high-dose nitroglycerin (30 mcg/min), which was titrated every 3 minutes, increasing by 15 mcg/min until a dose of 120 mcg/min was reached. After 18 minutes of aggressive therapy, the patient’s condition improved and he no longer required mechanical ventilation.
CONCLUSIONS: Hypertensive cardiogenic pulmonary edema is a challenging clinical condition that should be diagnosed and managed as early as possible, and distinguished from respiratory failure due to other causes. Although hypertensive cardiogenic pulmonary edema is usually managed acutely with high-dose diuretics, this case has highlighted the benefit of high-dose IV nitroglycerin, and review of the literature supports this treatment approach.

Keywords: Furosemide, Heart Failure, Nitroglycerin, Pulmonary Edema

Related Articles (0)

Coming Soon...

Published: 2019-01-19

Pitfalls of Diagnosing Left Lower Quadrant Pain Causes: Making the Uncommon Common Again

Christian Saliba, Samer H. Diab, Gregory Nicolas, Julien S. El Sayegh, Dani Osman, Jean Michel Azzo, Ali Dabbous, Hussein Hmadeh, Ali Wehbe, Houssein Haidar Ahmad

Am J Case Rep 2019; 20:78-82

DOI: 10.12659/AJCR.912226

Published: 2019-01-18

Tracheobronchopathia Osteochondroplastica: A Case Report Illustrating the Importance of Multilevel Workup...

Giulio Riva, Ilaria Girolami, Claudio Luchini, Manuela Villanova, Giovanni Valotto, Luca Cima, Rodolfo Carella, Maurizio Riva, Filippo Fraggetta, Luca Novelli, Albino Eccher

Am J Case Rep 2019; 20:74-77

DOI: 10.12659/AJCR.911859